170 related articles for article (PubMed ID: 12598336)
21. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
22. Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002.
Retsas S; Falkson C; Spitler L
Melanoma Res; 2002 Jun; 12(3):A1-4. PubMed ID: 12140389
[No Abstract] [Full Text] [Related]
23. Adjuvant treatment of colorectal cancer.
Midgley RS; Kerr DJ
Cancer Treat Rev; 1997 May; 23(3):135-52. PubMed ID: 9251719
[No Abstract] [Full Text] [Related]
24. Adjuvant treatment of colorectal adenocarcinoma.
Steele G; Posner MR
Curr Probl Cancer; 1993; 17(4):223-69. PubMed ID: 8269716
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of intralesional interferon in the reduction of extramedullary masses in a case of lymphoblastic leukosis].
Alba P; Franco R; Caballero D; León A
Sangre (Barc); 1991 Jun; 36(3):250. PubMed ID: 1948548
[No Abstract] [Full Text] [Related]
26. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma.
Bajetta E
Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604
[No Abstract] [Full Text] [Related]
27. Adjuvant treatment of colorectal cancer.
Saltz LB; Kelsen DP
Annu Rev Med; 1997; 48():191-202. PubMed ID: 9046955
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy of colorectal cancer: new perspectives after a long path.
Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
[TBL] [Abstract][Full Text] [Related]
29. [Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
Sakai T; Yamashita Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():460-3. PubMed ID: 14574935
[No Abstract] [Full Text] [Related]
30. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
31. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
Eng C; Abbruzzese JL
Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
[TBL] [Abstract][Full Text] [Related]
32. The treatment of metastatic melanoma with chemotherapy and biologics.
Atkins MB
Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
[TBL] [Abstract][Full Text] [Related]
33. Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies.
De Filippi R; Cucchiara G; Prete SP; Marini S; Ricci F; Nunziata C; Turriziani M; Bonmassar E; Fuggetta MP; De Vecchis L
Ann Oncol; 1991; 2(10):759-64. PubMed ID: 1801883
[TBL] [Abstract][Full Text] [Related]
34. Colorectal carcinoma: current problems and future perspectives.
Schmoll HJ
Ann Oncol; 1994; 5 Suppl 3():115-21. PubMed ID: 8204526
[TBL] [Abstract][Full Text] [Related]
35. Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?
Roviello G; Zanotti L; Correale P; Gobbi A; Wigfield S; Guglielmi A; Pacifico C; Generali D
Immunotherapy; 2017 Jan; 9(1):25-32. PubMed ID: 28000528
[TBL] [Abstract][Full Text] [Related]
36. The management of liver metastases.
Franco D
Br J Hosp Med; 1991 May; 45(5):284-5, 288-90. PubMed ID: 2065231
[TBL] [Abstract][Full Text] [Related]
37. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
Makower D; Wadler S
Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
[TBL] [Abstract][Full Text] [Related]
38. Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).
Labianca R; Pancera G; Barni S; Cascinu S; Comella G; Foa P; Martignoni G; Zaniboni A; Giaccon G; Luporini G
Adv Exp Med Biol; 1993; 339():233-7. PubMed ID: 8178720
[No Abstract] [Full Text] [Related]
39. Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
Soori GS; Oldham RK; Dobbs TW; Bury MJ; Church CK; DePriest C
Cancer Biother Radiopharm; 2000 Apr; 15(2):175-83. PubMed ID: 10803323
[TBL] [Abstract][Full Text] [Related]
40. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
